$16.10
0.221.39%
At Close: -
$16.08
-0.02-0.12%
After Hours: 5:10 PM EDT
15 minutes delayed
UroGen Pharma
URGNNASDAQ
UroGen Pharma (NASDAQ:URGN) Stock, Insider Trading Activity
UroGen Pharma: Insider buying and selling updated today.
Shares Outstanding
41.170M%
Institutional Shares Held
5.142M
Institutional Percentage Held
12.5%
| Jun 11, 2024 | Mark Schoenberg | CHIEF MEDICAL OFFICER | 4.847K | $13.08 | -$67.40K | SELL-OPTIONS | 3.48% | 144.284K | Jun 10 | View |
| Mar 20, 2024 | Mark Schoenberg | CHIEF MEDICAL OFFICER | -12K | $14.05 | -$168.60K | SELL | -7.92% | 139.437K | Mar 18 | View |
| Feb 02, 2024 | Jason D. Smith Attorney-in-Fact | GENERAL COUNSEL | 5.007K | $15.74 | -$78.59K | SELL-OPTIONS | 27.20% | 23.414K | Jan 31 | View |
| Feb 02, 2024 | Mark Schoenberg | CHIEF MEDICAL OFFICER | 2.877K | $15.74 | -$59.64K | SELL-OPTIONS | 1.94% | 151.437K | Jan 31 | View |
| Sep 05, 2023 | Jason D. Smith Attorney-in-Fact | GENERAL COUNSEL | 4.534K | $18.01 | -$68.44K | SELL-OPTIONS | 32.68% | 18.407K | Aug 31 | View |
| Feb 02, 2023 | Jason D. Smith Attorney-in-Fact | GENERAL COUNSEL | 1.697K | $10.12 | -$16.56K | SELL-OPTIONS | 13.94% | 13.873K | Jan 31 | View |
| Feb 02, 2023 | Mark Schoenberg | CHIEF MEDICAL OFFICER | 1.933K | $10.12 | -$19.23K | SELL-OPTIONS | 1.32% | 148.56K | Jan 31 | View |
| Nov 02, 2022 | Mark Schoenberg | CHIEF MEDICAL OFFICER | 242 | $11.85 | -$3.06K | SELL-OPTIONS | 1.02% | 23.95K | Oct 31 | View |
| Sep 02, 2022 | Jason D. Smith Attorney-in-Fact | GENERAL COUNSEL | 4.727K | $7.21 | -$26.00K | SELL-OPTIONS | 63.46% | 12.176K | Aug 31 | View |
| Aug 25, 2022 | Mark Schoenberg | CHIEF MEDICAL OFFICER | 241 | $7.81 | -$2.02K | SELL-OPTIONS | 1.03% | 23.708K | Jul 31 - Aug 01 | View |
| May 03, 2022 | Mark Schoenberg | CHIEF MEDICAL OFFICER | 246 | $6.62 | -$1.68K | SELL-OPTIONS | 1.06% | 23.467K | Apr 30 | View |
| Feb 02, 2022 | Jason D. Smith Attorney-in-Fact | GENERAL COUNSEL | 419 | $7.58 | -$3.14K | SELL-OPTIONS | 5.96% | 7.449K | Jan 31 | View |
| Feb 02, 2022 | Molly Henderson | CHIEF FINANCIAL OFFICER | 335 | $7.58 | -$2.51K | SELL-OPTIONS | 6.82% | 5.248K | Jan 31 | View |
| Feb 02, 2022 | Mark Schoenberg | CHIEF MEDICAL OFFICER | 1.126K | $7.58 | -$10.41K | SELL-OPTIONS | 5.10% | 23.221K | Jan 31 | View |
| Feb 02, 2022 | Elizabeth Barrett | CHIEF EXECUTIVE OFFICER | 10.138K | $7.58 | -$62.12K | SELL-OPTIONS | 3.40% | 308.358K | Jan 31 | View |
| Jan 28, 2022 | Mark Schoenberg | CHIEF MEDICAL OFFICER | 98 | $8.09 | -$897.99 | SELL-OPTIONS | 0.45% | 22.095K | Jan 26 | View |
| Jan 07, 2022 | Elizabeth Barrett | CHIEF EXECUTIVE OFFICER | 58.721K | $9.15 | -$429.76K | SELL-OPTIONS | 24.52% | 298.22K | Jan 03 - Jan 04 | View |
| Dec 02, 2021 | Jason Smith Attorney-in-Fact | GENERAL COUNSEL | 4.53K | $12.03 | -$45.75K | SELL-OPTIONS | 181.20% | 7.03K | Nov 30 | View |
| Dec 02, 2021 | Molly Henderson | CHIEF FINANCIAL OFFICER | 2.413K | $12.03 | -$31.12K | SELL-OPTIONS | 96.52% | 4.913K | Nov 30 | View |
| Nov 19, 2021 | Mark Schoenberg | CHIEF MEDICAL OFFICER | 160 | $13.10 | $2.10K | BUY | 0.73% | 21.997K | Nov 18 | View |
| Nov 02, 2021 | Mark Schoenberg | CHIEF MEDICAL OFFICER | 242 | $17.16 | -$4.43K | SELL-OPTIONS | 1.12% | 21.837K | Oct 31 - Nov 01 | View |
| Oct 28, 2021 | Mark Schoenberg | CHIEF MEDICAL OFFICER | 101 | $16.32 | -$1.75K | SELL-OPTIONS | 0.47% | 21.595K | Oct 26 - Oct 27 | View |
| Aug 03, 2021 | Mark Schoenberg | CHIEF MEDICAL OFFICER | 257 | $15.64 | -$3.80K | SELL-OPTIONS | 1.21% | 21.494K | Jul 31 - Aug 02 | View |
| Jul 28, 2021 | Mark Schoenberg | CHIEF MEDICAL OFFICER | -311 | $15.30 | -$1.58K | SELL | -1.47% | 20.821K | Jul 26 | View |
| May 18, 2021 | Molly Henderson | CHIEF FINANCIAL OFFICER | 2.5K | $15.85 | $39.63K | BUY | ∞ | 2.5K | May 17 | View |
| May 18, 2021 | Jason D. Smith | GENERAL COUNSEL | 2.5K | $15.71 | $39.27K | BUY | ∞ | 2.5K | May 17 | View |
| May 04, 2021 | Mark Schoenberg | CHIEF MEDICAL OFFICER | 257 | $20.00 | -$4.86K | SELL-OPTIONS | 1.23% | 21.132K | Apr 30 | View |
| Apr 27, 2021 | Mark Schoenberg | CHIEF MEDICAL OFFICER | 120 | $19.63 | -$1.75K | SELL-OPTIONS | 0.58% | 20.875K | Apr 26 | View |
| Feb 02, 2021 | Mark Schoenberg | CHIEF MEDICAL OFFICER | 924 | $22.07 | -$23.75K | SELL-OPTIONS | 4.66% | 20.755K | Jan 31 | View |
| Jan 26, 2021 | Mark Schoenberg | CHIEF MEDICAL OFFICER | 108 | $22.12 | -$2.21K | SELL-OPTIONS | 0.55% | 19.831K | Jan 26 | View |
| Dec 15, 2020 | Elizabeth Barrett | — | 10K | $18.50 | $185.00K | PURCHASE | 4.56% | 229.117K | Dec 14 | View |
| Dec 07, 2020 | Mark Schoenberg | — | 380 | $19.85 | -$13.14K | OPTION EXERCISE | 1.96% | 19.723K | Dec 04 | View |
| Oct 28, 2020 | Mark Schoenberg | — | 107 | $20.95 | -$2.12K | OPTION EXERCISE | 0.56% | 19.343K | Oct 26 | View |
| Oct 16, 2020 | PETER PFREUNDSCHUH | — | 2.517K | $21.77 | -$52.25K | OPTION EXERCISE | 31.91% | 10.405K | Oct 15 | View |
| Sep 08, 2020 | Mark Schoenberg | — | 693 | $20.20 | -$7.03K | OPTION EXERCISE | 3.74% | 19.236K | Sep 04 | View |
| Sep 01, 2020 | Peter Pfreundschuh Attorney-in-Fact | — | 533 | $22.82 | -$11.62K | OPTION EXERCISE | 7.25% | 7.888K | Sep 01 | View |
| Jul 28, 2020 | Peter Pfreundschuh Attorney-in-Fact | — | 276 | $23.51 | -$3.31K | OPTION EXERCISE | 3.90% | 7.355K | Jul 26 - Jul 27 | View |
| Jul 28, 2020 | Mark Schoenberg | — | 139 | $23.51 | -$1.65K | OPTION EXERCISE | 0.76% | 18.543K | Jul 26 - Jul 27 | View |
| Jun 05, 2020 | Mark Schoenberg | — | 693 | $27.51 | -$9.60K | OPTION EXERCISE | 3.91% | 18.404K | Jun 04 | View |
| May 20, 2020 | Peter Pfreundschuh Attorney-in-Fact | — | 683 | $25.07 | -$8.98K | OPTION EXERCISE | 10.68% | 7.079K | May 20 | View |
| Apr 28, 2020 | Mark Schoenberg | — | 138 | $24.35 | -$1.70K | OPTION EXERCISE | 0.79% | 17.711K | Apr 26 - Apr 27 | View |
| Apr 28, 2020 | Peter Pfreundschuh Attorney-in-Fact | — | 276 | $24.35 | -$3.43K | OPTION EXERCISE | 4.51% | 6.396K | Apr 26 - Apr 27 | View |
| Apr 28, 2020 | Stephen Mullennix | — | 272 | $24.35 | -$3.53K | OPTION EXERCISE | 2.77% | 10.084K | Apr 26 - Apr 27 | View |
| Feb 24, 2020 | Peter Pfreundschuh | — | 682 | $29.68 | -$10.68K | OPTION EXERCISE | 12.54% | 6.12K | Feb 20 | View |
| Feb 18, 2020 | Stephen Mullennix | — | 1.147K | $28.04 | -$17.16K | OPTION EXERCISE | 13.24% | 9.812K | Feb 14 | View |
| Jan 28, 2020 | Peter Pfreundschuh | — | 999 | $29.28 | -$19.53K | OPTION EXERCISE | 29.05% | 4.438K | Jan 26 - Jan 27 | View |
| Jan 28, 2020 | Stephen Mullennix | — | 982 | $29.26 | -$20.01K | OPTION EXERCISE | 12.78% | 8.665K | Jan 26 - Jan 27 | View |
| Jan 28, 2020 | Mark Schoenberg | — | 511 | $29.15 | -$9.39K | OPTION EXERCISE | 5.90% | 9.177K | Jan 26 - Jan 27 | View |
| Nov 22, 2019 | Elizabeth Barrett | CHIEF EXECUTIVE OFFICER | 7.53K | $28.00 | $210.84K | BUY | 83.50% | 16.548K | Nov 21 | View |
| Nov 22, 2019 | Elizabeth Barrett | CHIEF EXECUTIVE OFFICER | 7.47K | $28.00 | $209.16K | BUY | 482.56% | 9.018K | Nov 20 | View |
| Nov 22, 2019 | Peter Pfreundschuh Attorney-in-Fact | CHIEF FINANCIAL OFFICER | 688 | $28.41 | -$10.06K | SELL-OPTIONS | 25.01% | 3.439K | Nov 20 | View |
| Nov 21, 2019 | Mark Schoenberg | CHIEF MEDICAL OFFICER | 1.96K | $28.17 | $55.21K | BUY | 32.63% | 7.967K | Nov 19 | View |
| Nov 18, 2019 | Elizabeth Barrett | CHIEF EXECUTIVE OFFICER | 1.548K | $26.00 | $40.25K | BUY | ∞ | 1.548K | Nov 15 | View |
| Nov 18, 2019 | Stephen Mullennix | CHIEF OPERATING OFFICER | 1.151K | $26.00 | -$15.81K | SELL-OPTIONS | 17.62% | 7.683K | Nov 14 | View |
| Sep 06, 2019 | Mark Schoenberg | CHIEF MEDICAL OFFICER | 698 | $33.92 | -$11.63K | SELL-OPTIONS | 13.15% | 6.007K | Sep 04 | View |
| Aug 22, 2019 | Peter Pfreundschuh Attorney-in-Fact | CHIEF FINANCIAL OFFICER | 2.751K | $33.07 | -$46.83K | SELL-OPTIONS | ∞ | 2.751K | Aug 20 | View |
| Aug 16, 2019 | Stephen Mullennix | CHIEF OPERATING OFFICER | 1.151K | $31.65 | -$19.24K | SELL-OPTIONS | 21.39% | 6.532K | Aug 14 - Aug 15 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.